由于消费者需求和早期研究,兽医药物芬达醇重新获得了关注. Veterinary drug fenbendazole gains renewed interest amid consumer demand and early studies.

2026年, 药物重新使用的兴趣再次引起了兽医抗寄生虫剂芬达醇的关注. In 2026, renewed interest in drug repurposing has placed fenbendazole, a veterinary antiparasitic, in the spotlight. 虽然早期研究表明可能有好处,但专家强调需要进行临床试验,并且该药物尚未获得FDA批准用于人类. While early studies suggest potential benefits, experts emphasize that clinical trials are needed and the drug is not FDA approved for human use. 消费者需求增加,促使健康公司提供高纯度产品,尽管卫生专业人士建议在非标签使用之前谨慎和咨询. Consumer demand has increased, prompting wellness companies to offer high-purity products, though health professionals advise caution and consultation before off-label use.